Dr Emma Hodcroft Profile picture
Jul 15, 2021 8 tweets 5 min read Read on X
I've run preliminary @nextstrain focal builds on 20B/S:796H (B.1.1.318) (pictured) & 20A/S:210T (B.1.619).

These aren't part of CoVariants (yet?) but they've caught a couple eyes and I thought it was worth taking a closer look.

1/8 Image
20B/S:796H (B.1.1.318) is behind most of the recent increase in 'other' variants circulating in Greece (shown in grey on the CoVariants plot, below - disregard last point, low sequence #'s).

It's very prominent in Greece, but also found worldwide.

2/8

nextstrain.org/groups/neherla… ImageImage
Taking a closer look at Europe only, we can see there's a large cluster in Greece, but also distinct clusters in Switzerland & Ireland, & many sequences from other countries scattered between.

3/8

nextstrain.org/groups/neherla… Image
20B/S:796H (B.1.1.318) has spike mutations at S:95I, S:144-, S:484K, & S:681H which are shared with other Variants of Concern/Interest.

The distinct clusters in Switzerland, Greece, & Ireland generally don't have additional spike mutations.

4/8

covariants.org/shared-mutatio… ImageImage
The fact that the significant recent cluster in Greece (or the others) doesn't have additional spike mutations suggests (but doesn't rule out) that this expansion may *not* be due to viral changes.

A reminder that it's not just the virus that determines transmission!! 🧑🏽‍🤝‍🧑🏻

5/8 Image
20A/S:210T (B.1.619) was initially mostly seen in Africa & Europe & seemed to be decreasing in frequency, but has recently grown again, particularly in South Korea.

6/8

nextstrain.org/groups/neherla… Image
Looking just at Europe & Asia, we can see clusters in Germany, Switzerland, France, & Belgium, as well as the large South Korean cluster clearly.

7/8

nextstrain.org/groups/neherla… Image
20A/S:210T (B.1.619) has a number of spike mutations, but only S:484K & S:1027I are shared with other variants of concern.

Notably, the cluster in South Korea does not have additional Spike mutations, suggesting this also may not be spreading due to viral change.

8/8 ImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Emma Hodcroft

Dr Emma Hodcroft Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @firefoxx66

Sep 7, 2023
I'm excited to announce a new paper with @MLReichmuth and @C_Althaus, out now in @PLOSPathogens!

We used phylogenetics & modelling to investigate the introduction & expansion of #SARSCoV2 Alpha & Delta variants into #Switzerland & to simulate different interventions.

1/17 Image
First, we wanted to estimate the number of times Alpha & Delta were introduced into Switzerland before they were dominant.
For this we used sequences: we looked for where Swiss Alpha/Delta seqs descend from non-Swiss sequences - coming to Switzerland from elsewhere.

2/17
We looked at two ways of counting these introductions:

Liberal: every Swiss sequence coming from non-Swiss sequences is an introduction
Conservative: only the first Swiss sequence in a subtree of mixed-Swiss-non-Swiss sequences is an introduction

3/17 Image
Read 17 tweets
Jun 15, 2023
Benevolent dictators have no place in academic science.

I don't care if they usually make the right decision. Or if people don't think they've abused their power yet.

Science should not depend on one person being well-behaved.
Balance should be built in, power distributed.

1/5
"If you want to go fast, go alone, if you want to go far, go together" the African proverb says.

Can driven, visionary people start up groundbreaking ideas & cut through barriers to implement them? Absolutely! This 100% is part of science.

2/5
But if you want your idea to be a keystone of science communities & the public, you have to make it about more than *you*.

If you want to run a private business, go do that.
If you want to be keystone of public science, you have to be transparent, trustworthy, & stable.

3/5
Read 5 tweets
Apr 28, 2023
🎉CoVariants.org Update!🎉

23B (XBB.1.16) is now available on CoVariants! It's visible as part of Per Country & Per Variant plots, on the shared mutation page - and of course, has a page of its own.

1/10

#XBB116 #23B #Arcturus
📷 Image
This is in line with the recent addition of 23B (XBB.1.16) as a @nextstrain clade - read more on that below 👇🏻!

2/10

As I covered earlier, 23B (XBB.1.16) is descended from the recombinant 22F (XBB) variant, with some additional mutations. You can read more about how it evolved & acquired those mutations below 👇🏻.

3/10

Read 10 tweets
Apr 20, 2023
A Q I've seen: "How did this stay quiet so long?"

Quote from the article:
"Many sources who spoke to Science declined to be named out of fear of legal action from Bogner or of losing GISAID access."

Scientists depend on GISAID access. Fear is powerful.

science.org/content/articl…
Also from this article:
'Marion Koopmans ... says she has received multiple calls from Bogner“with a rather intimidating tone.” So have colleagues, she adds. “I have heard similar experiences from quite a few.”'
And:
"And Science heard many stories about researchers who saw their data curtailed, or cut off, without explanation. Some linked the actions to their being critical of GISAID or being seen as a potential threat."
Read 8 tweets
Apr 4, 2023
If you're an early career researcher (yes even 'just' a PhD student!) 1 of my biggest pieces of advice would be:
Go claim/create your Google Scholar page!! 👈🏻✍️🏻

I put this off bc I thought I 'didn't have enough on it'. I also generally thought "nobody is looking for me".

1/4
Now that I'm (a little) on the other end, I see how wrong I was.

It's *just fine* to not have "much" in your Google Scholar profile - anyone worth their salt will be evaluating you relative to your career state.
Much more important: to be findable!

2/4
And alongside that: it's so useful to have an easy way for people to see what your field is & what you've been up to/who you work with/your expertise.

Google Scholar is also pretty easy to maintain (will vary depending on how unique your name is), as it auto-updates.

3/4
Read 6 tweets
Feb 14, 2023
🎉 CoVariants.org Update! 🎉

23A (XBB.1.5) is now available on CoVariants! It's visible as part of Per Country & Per Variant plots, on the shared mutation page - and of course, has a page of its own.

1/9

#XBB15 #23A Image
This is in line with the recent addition of 23A (XBB.1.5) as a @nextstrain clade - read more on that below 👇🏻!

2/9

As I covered earlier, 23A (XBB.1.5) is descended from the recombinant 22F (XBB) variant, with some additional mutations. You can read more about how it evolved & acquired those mutations below 👇🏻.

3/9

Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(